14交易日12涨停的合富中国（603122）停牌核查完成，明天（2025年11月20日）开市起复牌。 11月19日晚，合富中国停牌核查迎来进展。该公司公告，近期，公司就股票交易异常波动及严重异常波 动的相关事项进行了核查。鉴于相关核查工作已完成，经公司向上交所申请，公司股票将于2025年11月 20日（星期四）开市起复牌。 合富中国表示，经公司自查，公司目前日常经营活动一切正常，公司内外部经营环境未发生重大变化， 公司未发现其他有可能对公司股价产生较大影响的重大事件，公司董事、高级管理人员、控股股东及间 接控股股东在公司本次股票交易异常波动期间不存在买卖公司股票的情况。 合富中国主营体外诊断产品集约化业务，2008年曾于全国率先推出为医院提供体外诊断试剂集采服务。 目前，合富中国最新股价为23.8元/股，总市值94.74亿元。 2025年10月28日至2025年11月14日期间，该公司股票连续14个交易日中有12个交易日以涨停价收盘，并 5次触及股价异常波动、3次触及严重异常波动情形，其间累计涨幅高达256.29% 合富中国称，公司最新市盈率水平显著高于同行业上市公司水平，当前股价存在明显泡沫化特征。截至 2 ...

Core Viewpoint - The stock of HeFu China (603122) will resume trading on November 20 after a suspension for verification of stock trading due to significant price fluctuations and abnormal trading activities [2] Summary by Relevant Sections Stock Performance - From October 28 to November 14, HeFu China's stock experienced a cumulative increase of 256.29%, with 12 out of 14 trading days closing at the daily limit price [2] - The stock has encountered five instances of abnormal price fluctuations and three instances of severe abnormal fluctuations during this period [2] Company Operations - HeFu China confirmed that its daily operations are normal and that there have been no significant changes in its internal or external operating environment [2] - The company's board of directors stated that there are no undisclosed matters that should have been disclosed according to the Shanghai Stock Exchange's listing rules, nor are there any ongoing negotiations or agreements that could significantly impact the stock price [2]

Core Viewpoint - The stock price of the company has significantly outperformed the Shanghai Composite Index, with a cumulative increase of 61.06% from November 12 to 18, 2025, while the index decreased by 1.57% during the same period [1] Financial Performance - For the period from January to September 2025, the company's revenue was 63,313.33 million, representing a year-on-year decline of 6.02% [1] - The company's net profit after deducting non-recurring items was -2,433.96 million, showing a year-on-year decrease of 17.38% [1] Market Activity - The average turnover rate of the company's stock increased from 1.21% to 5.22%, indicating heightened trading activity [1] - The company's price-to-earnings ratio, after excluding non-recurring items, stands at 47.7 times, which is higher than the industry average [1] Risk Factors - There is a potential risk of stock price speculation, which may lead to a significant decline in the stock price [1] - The company has not disclosed any significant undisclosed matters and is not involved in any trending concepts [1]

Core Viewpoint - The company *ST Muban has experienced significant stock price volatility, with a cumulative deviation of 12% over three consecutive trading days, indicating abnormal fluctuations [1] Financial Performance - For the period of January to September 2025, the company reported revenue of 227 million yuan and a net loss of 356 million yuan [1] - If the annual revenue for 2025 falls below 300 million yuan and the total profit is negative, the company may face delisting after the annual report is disclosed [1] Legal and Regulatory Issues - The company and its actual controller, Liao Zhiyuan, are under investigation [1] - There are unresolved issues regarding the occupation of funds by the controlling shareholder and related parties [1] - The uncertainty surrounding the company's ability to enter restructuring procedures remains [1]

8连板孚日股份(002083)11月17日披露公司股价严重异常波动的公告称，公司子公司山东孚日新能源材料有限公司（简称"孚日新能源"）于2021年投资建 设了锂电池电解液添加剂项目，2025年前三季度孚日新能源营业收入16839.81万元，占公司前三季度营业收入的4.38%，收入占公司主营业务收入比例较 小，对公司业绩影响有限。 孚日新能源目前暂无扩产计划，对公司其他业务布局不产生重大影响。公司股票价格自11月3日至11月17日累计涨幅达112.35%，已严重偏离公司基本面， 可能存在非理性炒作，交易风险大，存在短期下跌的风险。 | 分时 | 日 K | 同花顺F10~ | 诊股 | 品示 | 画线 | | 孚日股份 002083 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 创历史新高 | 创一年新高 | | | | | | 12.72↑ +1.16 +10.03% | | | | | | | > MA MA5:10.60 MA10:8.64 MA20:7.26 MA30:6.58 MA60:5.7 ...

智通财经APP讯，平潭发展(000592.SZ)公告，公司股票自2025年10月17日至11月17日以来价格涨幅为 255.19%，期间于10月20日、10月27日、10月30日、11月3日、11月5日、11月14日，6次触及股票交易异 常波动情形;于11月3日，1次触及股票交易严重异常波动情形。公司股票短期内价格涨幅较大，已严重 背离公司基本面。公司股票自2025年11月18日开市起停牌，待核查结束并披露相关公告后复牌，预计停 牌时间不超过3个交易日。 ...

以下文章来源于中新经纬 ，作者周奕航 对于是否关注到市场上关于公司名字的讨论，上述接线人员说，"股价上涨与公司名字无关，那是网友们自己想的。" 此外，孚日股份16日发布股价异常波动公告称，目前公司股票波动异常，可能存在非理性炒作，交易风险大，存在短期下跌的风险。请广大投资者注 意交易风险，切勿盲目跟风，理性决策，审慎投资。 中新经纬 . 中新经纬是由中国新闻社主办的财经新媒体，拥有中国互联网新闻信息采编发布服务资质。以手机客户端（APP）等为主要传播平台，以"权威、前瞻、专 业、亲和"为特色宗旨，传播财经资讯、解读经济政策、讲述商界故事，打造精英的财经资讯平台。 来源|中新经纬 文| 周奕航 编辑|李晓萱 17日，孚日股份在集合竞价阶段即封住涨停，走出8连板，股价也飙涨至12.72元/股的历史新高，总市值突破120亿元。 对于股价上涨，17日，中新经纬以投资者身份致电孚日股份董秘办，一位接线人员表示，近期公司股价上涨与 电解液添加剂VC （碳酸亚乙烯酯）价 格上涨有关。 截至目前，VC价格已从底部4.5万元/吨涨至超10万元/吨，涨幅达150%。 公告称，2025年前三季度，公司实现营业收入38.41亿元，同 ...

Core Viewpoint - The stock of Hefei (China) Medical Technology Co., Ltd. has experienced a significant surge, with 12 out of 14 trading days resulting in price limits, leading to a suspension for verification due to a stark divergence from the company's financial performance [1][2]. Financial Performance - Hefei China's revenue has declined from a peak of 1.28 billion yuan in 2022 to an estimated 1.093 billion yuan in 2023, representing a year-on-year decrease of 22.8% to 549 million yuan in the first three quarters [3][4]. - The net profit attributable to shareholders has also dropped significantly, falling by 42.96% to 47.19 million yuan in 2023, with a projected further decline of 41.58% to 27.57 million yuan in 2024 [3][4]. - The company reported a net loss of 12.39 million yuan in the first three quarters of 2023, with a dramatic decline of 225.26% in the third quarter [3][4]. Stock Performance and Market Reaction - The stock price fluctuated between 6-7 yuan per share until a surge began on October 28, reaching 23.8 yuan per share by November 14, marking a cumulative increase of 256.29% [1][2]. - The trading volume saw a high turnover rate of 28.48% on November 14, indicating speculative trading behavior [2][5]. - The static price-to-earnings ratio reached 343.67 times, significantly higher than the industry average of 30.94 times, suggesting a severe overvaluation risk [6]. Business Strategy and Adjustments - In response to declining revenue, the company is actively adjusting its business strategy, focusing on the development of proprietary products and expanding its market development team [4]. - The company aims to diversify its business beyond the current procurement model to ensure sustainable growth, particularly through the ACME project [4].

人民同泰公告称，公司股票于2025年11月14日、17日连续2日涨幅偏离值累计达20%，属异常波动。11 月10 - 17日，公司股票连续6日涨停，累计涨幅77.21%，换手率波动大，股价涨幅高于同期行业指数及 上证指数。截至11月14日，公司滚动市盈率73.64，远高于行业的18.91。2025年前三季度，公司营收 784,592.89万元，同比增2.19%；净利润11,187.65万元，同比降45.69%。经核实，不存在应披露未披露 重大事项，相关人员在此期间无买卖公司股票情况。 ...

时空科技公告，公司股票价格于2025年11月13日、11月14日、11月17日连续三个交易日收盘价格涨幅偏 离值累计超过20%，属于股票交易异常波动的情形。公司股价自2025年9月以来累计上涨258.73%，自 2025年10月31日以来日均换手率为22.75%，换手率较高，明显放量，交易风险较大。公司股价短期上 涨幅度较大，存在市场情绪过热、非理性炒作风险，已严重偏离同期上证指数和装修装饰行业指数，且 严重偏离公司基本面，随时存在快速下跌风险。 ...